Obregón-García JA, Múzquiz-Zermeño D, Navarrete-Solís J

Language: Spanish
References: 14
Page: 92-95
PDF size: 317.48 Kb.

ABSTRACT

Introduction: in patients with primary immunodeficiencies (PID), skin manifestations are common, which may be similar to those in patients with atopic dermatitis (AD). Objective: to compare the dermatological manifestations of patients with PID with those of patients with AD. Material and methods: retrospective, observational and comparative study. Fifty patients with AD and 48 with PID treated at the High Specialty Medical Unit No. 25, located in Monterrey, Nuevo León, were included. Results: the mean age was 7.1 years; there was a predominance of male patients (61.2%). In patients with AD, xerosis (n = 22, 44%) was the most common skin manifestation, followed by eczema (n = 19, 38%). In contrast, eczema (n = 37, 77.1%) was more frequent in the PID group. Infectious skin complications occurred in both groups of patients, but were more severe in patients with PID. Conclusions: there are differences in the skin manifestations of patients with AD and PID, which may help to improve the diagnostic process in patients with PID.

REFERENCES

1. Relan M, Lehman HK. Common dermatologic manifestations of primary immune deficiencies. Curr Allergy Asthma Rep. 2014; 14(12): 480.

2. Kilic SS, Ozel M, Hafizoglu D, Karaca NE, Aksu G, Kutukculer N. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey--two centers study. J Clin Immunol. 2013; 33(1): 74-83.

3. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020; 40(1): 24-64.

4. Basak R, Abdelhakim S, Cafone J. Cutaneous manifestations of primary immunodeficiency. Ind J Paediatr Derm. 2017; 18(3): 155.

5. Mancini AJ, Chan LS, Paller AS. Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature. J Am Acad Dermatol. 1998; 38(2 Pt 2): 295-300.

6. Lewis DJ, Wu JH, Boyd M, Duvic M, Feldman SR. Cutaneous manifestations of genodermatoses and primary immunodeficiency. Dermatol Online J. 2019; 25(6): 13030/qt1gj1n07j.

7. Al-Herz W, Nanda A. Skin Manifestations in primary immunodeficient children. Pediatr Dermatol. 2011; 28(5): 494-501.

8. Berron-Ruiz A, Berron-Perez R, Ruiz-Maldonado R. Cutaneous markers of primary immunodeficiency diseases in children. Pediatr Dermatol. 2000; 17(2): 91-96.

9. Liquidano-Pérez E, Maza-Ramos G, Yamazaki-Nakashimada M, Barragán-Arévalo T, Lugo-Reyes SO, Scheffler-Mendoza SC et al. Inmunodeficiencia combinada debida a deficiencia de DOCK8. Lo que sabemos hasta ahora. Rev Alerg Méx. 2022; 69(1): 31-47.

10. Nepesov S, Firtina S, Aygun FD, Burtenece N, Cokugras H, Camcioglu Y. Diagnosis of primary immunodeficiency diseases in pediatric patients hospitalized for recurrent, severe, or unusual infections. Allergol Immunopathol (Madr). 2022; 50(4): 50-56.

11. Gür-Cetinkaya P, Sahiner ÜM. Childhood atopic dermatitis: current developments, treatment approaches, and future expectations. Turk J Med Sci. 2019; 49(4): 963-984.

12. Pucci N, Novembre E, Cammarata MG, Bernardini R, Monaco MG, Calogero C et al. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy. 2005; 60(1): 113-116.

13. Eldeniz FC, Gul Y, Yorulmaz A, Guner SN, Keles S, Reisli I. Evaluation of the 10 warning signs in primary and secondary immunodeficient patients. Front Immunol. 2022; 13: 900055.

14. Bahrami A, Sayyahfar S, Soltani Z, Khodadost M, Moazzami B, Rezaei N. Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: a cross-sectional study in Iran. Allergol Immunopathol (Madr). 2020; 48(6): 711-719.